Howard Hughes, Pfizer Will Head Higher Says Becker Fund Manager

TheStreet.com Videos
Pfizer's stock may currently be out of favor, but the drug giant's fortunes will soon turn due to its strong cash flow and undervalued pipeline, said Andy Murray, portfolio manager for the Becker Value Equity Fund. Murray added that Pfizer could make another run at AstraZeneca due to its solid balance sheet. Murray is also bullish on Western Union's stock, saying the money transfer company will continue to profit from cross border transactions where there are significant barriers to entry. Finally, Murray is positive on the Howard Hughes Corporation because of its diversified real estate holdings across hot markets like Hawaii and Texas.
View Comments (0)